Purchases and Sales Made in Q4 2023 in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during Q4 2023. The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 08, 2024
Q4 2023
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-30.7K- 12.36% |
$975K - $1.51M
|
218K
$9.38M
|
|
|
Feb 14, 2024
Q4 2023
|
Amundi
Paris, I0 |
SELL
|
- |
-33.1K- 25.83% |
$1.05M - $1.63M
|
94.9K
$4.09M
|
|
|
Feb 14, 2024
Q4 2023
|
Fred Alger Management, LLC
New York, NY |
SELL
|
- |
-34.9K- 5.46% |
$1.11M - $1.72M
|
604K
$26M
|
|
|
Feb 13, 2024
Q4 2023
|
First Trust Advisors LP
Wheaton, IL |
SELL
|
- |
-38.6K- 3.21% |
$1.23M - $1.9M
|
1.16M
$50M
|
|
|
Feb 14, 2024
Q4 2023
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-40.6K- 17.69% |
$1.29M - $2M
|
189K
$8.13M
|
|
|
Feb 14, 2024
Q4 2023
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-58.1K- 22.42% |
$1.84M - $2.86M
|
201K
$8.65M
|
|
|
Feb 09, 2024
Q4 2023
|
Neuberger Berman Group LLC
New York, NY |
SELL
|
- |
-63.2K- 47.55% |
$2.01M - $3.11M
|
69.7K
$3M
|
|
|
Jan 17, 2024
Q4 2023
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-68.4K- 32.42% |
$2.17M - $3.36M
|
143K
$6.13M
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-78.3K- 34.03% |
$2.48M - $3.85M
|
152K
$6.53M
|
|
|
Feb 14, 2024
Q4 2023
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-79.4K- 10.92% |
$2.52M - $3.91M
|
648K
$27.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-91.5K- 72.03% |
$2.9M - $4.5M
|
35.5K
$1.53M
|
|
|
Feb 09, 2024
Q4 2023
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-95.8K- 52.56% |
$3.04M - $4.71M
|
86.5K
$3.72M
|
|
|
Jan 24, 2024
Q4 2023
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-103K- 48.64% |
$3.26M - $5.05M
|
108K
$4.66M
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-236K- 60.38% |
$7.5M - $11.6M
|
155K
$6.67M
|
|
|
Feb 14, 2024
Q4 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-244K- 33.27% |
$7.75M - $12M
|
490K
$21.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-614K- 85.69% |
$19.5M - $30.2M
|
103K
$4.41M
|
|
|
Feb 14, 2024
Q4 2023
|
Avoro Capital Advisors LLC
New York, NY |
SELL
|
- |
-1.15M- 76.67% |
$36.5M - $56.6M
|
350K
$15.1M
|